Search

everythinglearnresearchcommunity

for

Search:↓

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Men with lower 2nd to 4th finger ratios tend to have larger sinus volumes.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

A new method accurately measures nine specific hormones in human blood.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Taking 1 mg finasteride for a year reduces dihydrotestosterone levels in men with early hair loss, but doesn't change their metabolic state.

Exosomes may help stimulate hair growth and improve hair loss conditions like androgenic alopecia.

Serum AMH levels are a strong marker for diagnosing PCOS in Indian women.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

The method accurately measures 19 steroid hormones in human blood and urine using a small sample and is suitable for large-scale monitoring.

The methods accurately measure finasteride and tadalafil in Entadfi™ capsules for quality control.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

A new green method accurately measures finasteride and tadalafil in drugs and plasma.